Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Panchaud

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Viruses|August 28, 2021
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199"Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
The American Journal of Psychiatry|April 3, 2008
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancyAdrienne Einarson, Alessandra Pistelli, Marco DeSantis, et al.
Journal of Psychiatric Research|August 16, 2017
Use of atypical antipsychotics in pregnancy and maternal gestational diabetesAlice Panchaud, Sonia Hernandez-Diaz, Marlene P Freeman, et al.
Research in Social & Administrative Pharmacy : RSAP|October 26, 2025
Academic community pharmacy: A pilot Delphi study aimed at establishing a future common definition at the international levelClémence Perraudin, Noelia Amador-Fernandez, Marie Paule Schneider, et al.
British Journal of Clinical Pharmacology|January 25, 2026
Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION projectSarah Baklouti, Virginie Rigourd, Alice Panchaud, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individualsCatalina Barceló, Frédéric Gaspar, Manel Aouri, et al.
BMC Pregnancy and Childbirth|April 16, 2025
Risk of adverse obstetrical and neonatal outcomes in women consuming recreational drugs during pregnancySreemanjari Kandhasamy, Karine Lepigeon, Stéphanie Baggio, et al.
Swiss Medical Weekly|October 14, 2025
Initial COVID-19-related restrictions (lockdown) in 2020 and birth outcomes in Switzerland: an observational study based on statistics of outpatient midwifery servicesMarlene S Rauch, Alexandra Ruchti, Lara Eichelsberger, et al.
Journal of Affective Disorders|February 25, 2026
Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims dataAlessia Danelli, Carole A Marxer, Sereina M Graber, et al.
Viruses|July 2, 2021
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in SwitzerlandSarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Viruses|August 28, 2021
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199"Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
The American Journal of Psychiatry|April 3, 2008
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancyAdrienne Einarson, Alessandra Pistelli, Marco DeSantis, et al.
Journal of Psychiatric Research|August 16, 2017
Use of atypical antipsychotics in pregnancy and maternal gestational diabetesAlice Panchaud, Sonia Hernandez-Diaz, Marlene P Freeman, et al.
Research in Social & Administrative Pharmacy : RSAP|October 26, 2025
Academic community pharmacy: A pilot Delphi study aimed at establishing a future common definition at the international levelClémence Perraudin, Noelia Amador-Fernandez, Marie Paule Schneider, et al.
British Journal of Clinical Pharmacology|January 25, 2026
Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION projectSarah Baklouti, Virginie Rigourd, Alice Panchaud, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individualsCatalina Barceló, Frédéric Gaspar, Manel Aouri, et al.
BMC Pregnancy and Childbirth|April 16, 2025
Risk of adverse obstetrical and neonatal outcomes in women consuming recreational drugs during pregnancySreemanjari Kandhasamy, Karine Lepigeon, Stéphanie Baggio, et al.
Swiss Medical Weekly|October 14, 2025
Initial COVID-19-related restrictions (lockdown) in 2020 and birth outcomes in Switzerland: an observational study based on statistics of outpatient midwifery servicesMarlene S Rauch, Alexandra Ruchti, Lara Eichelsberger, et al.
Journal of Affective Disorders|February 25, 2026
Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims dataAlessia Danelli, Carole A Marxer, Sereina M Graber, et al.
Viruses|July 2, 2021
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in SwitzerlandSarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
Pageof 14